Filter
1

Study With [225Ac]Ac-FL-020 in mCRPC Participants

for
Metastatic Castration-resistant Prostate Cancer
Location: Charlottesville VA, Cleveland OH, Duarte CA, Irvine CA,
Sponsor: Full-Life Technologies GmbH

Sex: Male

Age: 18+

Code: NCT06492122

Phase1, Recruiting

Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes

for
Metastatic Castration-resistant Prostate Cancer,
Location: Quebec, Montreal, Ottawa, Toronto, Brampton, Kitchener,
Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06439225

Phase3, Recruiting

Castrate Resistant Prostate Cancer Enhertu Therapy

for
Prostate Cancer Metastatic, Prostate Cancer, CRPC
Location: Washington D.C. DC
Sponsor: Washington D.C. Veterans Affairs Medical Center

Sex: Male

Age: 18+

Code: NCT06610825

Phase2, Recruiting

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

for
Prostate Cancer, Prostatic Neoplasms
Location: New York NY, Albany NY, Myrtle Beach SC, Durham NC,
Sponsor: Clarity Pharmaceuticals Ltd

Sex: Male

Age: 18+

Code: NCT06056830

Phase3, Recruiting

High-Dose-Rate Brachytherapy

for
Patients With Prostate Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Male

Age: 18+

Code: NCT00913939

Recruiting

Interested in new prostate cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies

for
Prostate Cancer, Liver Cancer, Breast Cancer, Colon Cancer,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT00451022

Recruiting

Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program

for
Prostate Cancer
Location: St. John's, Halifax, Charlottetown, Saint John, Quebec,
Sponsor: Gabriela Ilie

Sex: Male

Age: 18+

Code: NCT04895839

Recruiting

A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy

for
Castration Sensitive Prostate Cancer
Location: Little Rock AR
Sponsor: University of Arkansas

Sex: Male

Age: 18 - 70+

Code: NCT06044025

Phase1, Recruiting

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

for
Cervical Cancer, Breast Cancer, Colon Cancer, NSCLC,
Location: Glen Burnie MD, Lexington KY, Omaha NE
Sponsor: Orano Med Theranostics, SAS

Sex: All

Age: 18+

Code: NCT05283330

Phase1, Recruiting

Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer

for
Castration-Sensitive Prostate Carcinoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: Male

Age: 18+

Code: NCT04734730

Phase2, Recruiting

Active Surveillance SNEP Assay Registry Trial for Prostate Cancer

for
Prostate Cancer Aggressiveness
Location: Royal Oak MI
Sponsor: Immunis.AI

Sex: Male

Age: 40 - 70+

Code: NCT04052048

Recruiting

Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

for
Prostate Cancer
Location: Bala-Cynwyd PA
Sponsor: MidLantic Urology

Sex: Male

Age: 18+

Code: NCT05799248

Phase3, Recruiting

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

for
Castrate Resistant Prostate Cancer, NUT Carcinoma,
Location: Boston MA, Jacksonville FL, Rochester MN, Houston TX,
Sponsor: Epigenetix, Inc.

Sex: All

Age: 18+

Code: NCT05488548

Phase1, Recruiting

Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy

for
Advanced Prostate Carcinoma, Metastatic Prostate Carcinoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: Male

Age: 60+

Code: NCT05869682

Phase2, Recruiting

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

for
Prostate Cancer (Adenocarcinoma), Prostate CA, Prostate Cancers,
Location: Myrtle Beach SC, Gahanna OH
Sponsor: Cellvax Therapeutics Inc

Sex: Male

Age: 0+

Code: NCT06636682

Phase2, Recruiting

Comparison of a Novel Transperineal Targeted Fusion Biopsy System to Conventional Transrectal Targeted Fusion Biopsy

for
Prostate Cancer
Location: Ottawa
Sponsor: Dr. Nicola Schieda

Sex: Male

Age: 0+

Code: NCT03936127

Recruiting

Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer

for
Prostate Cancer
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: Male

Age: 18+

Code: NCT00681694

Recruiting

PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer

for
Prostate Cancer
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: Male

Age: 18+

Code: NCT03594760

Phase3, Recruiting

T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer

for
Prostate Cancer
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: Male

Age: 18+

Code: NCT05586360

Phase2, Recruiting

PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores

for
Prostate Cancer, Recurrent Prostate Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: Male

Age: 18+

Code: NCT03495427

Phase2, Phase3, Recruiting